The Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain … (NCT07018375) | Clinical Trial Compass
Not Yet RecruitingPhase 4
The Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Thoracoscopic Lobectomy
320 participantsStarted 2026-01-06
Plain-language summary
The primary objective is to evaluate the impact of oliceridine versus sufentanil for perioperative analgesia on the incidence of chronic postsurgical pain (CPSP) in patients undergoing video-assisted thoracoscopic surgery.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ①Age 18-75 years, ASA physical status I-III, BMI 18-30 kg/m²;
* Scheduled for unilateral video-assisted thoracoscopic surgery (VATS) lung resection, including wedge resection, segmentectomy, lobectomy, or radical resection for lung cancer;
* Preoperative pain score \<1 on the Numeric Rating Scale (NRS);
* Ability to understand the study objectives and procedures, with voluntary informed consent obtained;
* Expected postoperative recovery in the general ward setting.
Exclusion Criteria:
* â‘ History of chronic pain or long-term analgesic use prior to surgery;
* Previous ipsilateral thoracic surgery;
* Prior neoadjuvant radiotherapy or chemotherapy;
* Severe cardiovascular or cerebrovascular disease, or hepatic/renal dysfunction (ALT/AST \>3× upper limit of normal; eGFR \<60 mL/min/1.73m²);
* Concurrent malignancy or active infection;
* Pre-existing psychiatric disorders or communication barriers precluding study participation;
* Known hypersensitivity to study medications (opioids, adjuvant analgesics, anesthetics, or antiemetics);
* Any condition deemed unsuitable for study participation by the investigator
What they're measuring
1
Incidence of chronic pain after surgery
Timeframe: from day 1 to day 90 after surgery
Trial details
NCT IDNCT07018375
SponsorTianjin Medical University General Hospital